|  |
| |
| Artikel-Nr.:
858A-9783030074920 Herst.-Nr.:
9783030074920 EAN/GTIN:
9783030074920 |
| |
|
| | |
| The purpose of this book is to give a concise introduction to development and analysis of pharmaceutical biologics for those in the pharmaceutical industry who are switching focus from small molecules to biologics processing, analysis, and delivery. In order to maintain a limited focus, Introduction to Biologic and Biosimilar Product Development and Analysis, will deal only with peptides, proteins and monoclonal antibodies. Weitere Informationen: | | Author: | Karen M. Nagel | Verlag: | Springer International Publishing | Sprache: | eng |
|
| | |
| | | |
| Weitere Suchbegriffe: recombinant DNA technology, Therapeutic Proteins, Therapeutic antibodies, Biologics analysis, biologics regualtion, Biologics analysis; Therapeutic antibodies; Therapeutic proteins; biologics regualtion; recombinant DNA technology |
| | |
| |